Gene Symbol | Gene ID | Gene Info |
---|---|---|
BPTF
|
ENSG00000171634.12 | bromodomain PHD finger transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_65825290_65825441 | BPTF | 3107 | 0.223848 | 0.78 | 1.2e-02 | Click! |
chr17_65821514_65821703 | BPTF | 32 | 0.974161 | 0.72 | 3.0e-02 | Click! |
chr17_65822293_65822503 | BPTF | 140 | 0.954894 | 0.48 | 1.9e-01 | Click! |
chr17_65826464_65826615 | BPTF | 4281 | 0.196577 | -0.48 | 2.0e-01 | Click! |
chr17_65822638_65823477 | BPTF | 799 | 0.605384 | 0.40 | 2.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_42055859_42056077 | 2.19 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
82 |
0.97 |
chr7_150328781_150329037 | 1.94 |
GIMAP6 |
GTPase, IMAP family member 6 |
525 |
0.79 |
chr1_239883177_239883989 | 1.93 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
740 |
0.59 |
chr17_29646389_29646953 | 1.92 |
CTD-2370N5.3 |
|
822 |
0.44 |
chr19_7410752_7411085 | 1.82 |
CTB-133G6.1 |
|
2930 |
0.22 |
chr2_158295494_158296053 | 1.74 |
CYTIP |
cytohesin 1 interacting protein |
153 |
0.96 |
chr1_198609469_198609717 | 1.71 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
1301 |
0.54 |
chr16_79630640_79632238 | 1.70 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
2360 |
0.43 |
chr1_24831599_24831750 | 1.67 |
RCAN3 |
RCAN family member 3 |
2287 |
0.27 |
chr11_6767215_6767876 | 1.63 |
OR2AG2 |
olfactory receptor, family 2, subfamily AG, member 2 |
22741 |
0.11 |
chr7_106505707_106506635 | 1.61 |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
247 |
0.95 |
chr9_123639853_123640396 | 1.59 |
PHF19 |
PHD finger protein 19 |
518 |
0.78 |
chr6_36511904_36512137 | 1.55 |
STK38 |
serine/threonine kinase 38 |
3227 |
0.19 |
chr1_111212990_111213454 | 1.52 |
KCNA3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
4433 |
0.21 |
chr7_38398302_38398591 | 1.50 |
AMPH |
amphiphysin |
104267 |
0.08 |
chr11_5713127_5713492 | 1.48 |
TRIM22 |
tripartite motif containing 22 |
1052 |
0.38 |
chr4_143325352_143326244 | 1.46 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
26614 |
0.28 |
chr2_113933295_113933446 | 1.45 |
AC016683.5 |
|
433 |
0.74 |
chr1_9847340_9847491 | 1.44 |
CLSTN1 |
calsyntenin 1 |
35776 |
0.13 |
chr8_134070006_134070389 | 1.42 |
SLA |
Src-like-adaptor |
2406 |
0.36 |
chr20_35643588_35643790 | 1.41 |
RBL1 |
retinoblastoma-like 1 (p107) |
52769 |
0.13 |
chr11_59320728_59320879 | 1.41 |
ENSG00000252893 |
. |
5470 |
0.14 |
chr3_56949638_56949992 | 1.38 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
684 |
0.75 |
chr13_31310422_31310683 | 1.37 |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
907 |
0.71 |
chr21_32532372_32532523 | 1.36 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
29908 |
0.23 |
chr19_17958139_17958290 | 1.34 |
JAK3 |
Janus kinase 3 |
612 |
0.6 |
chr11_95987293_95987883 | 1.34 |
ENSG00000266192 |
. |
87014 |
0.09 |
chr2_240302618_240303103 | 1.33 |
HDAC4 |
histone deacetylase 4 |
19783 |
0.17 |
chr6_2902429_2902783 | 1.33 |
SERPINB9 |
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
908 |
0.57 |
chr1_114413652_114413958 | 1.29 |
PTPN22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
515 |
0.69 |
chr14_22979723_22979978 | 1.29 |
TRAJ15 |
T cell receptor alpha joining 15 |
18730 |
0.09 |
chr6_31802179_31802624 | 1.27 |
C6orf48 |
chromosome 6 open reading frame 48 |
3 |
0.87 |
chr14_99736204_99736825 | 1.26 |
BCL11B |
B-cell CLL/lymphoma 11B (zinc finger protein) |
1051 |
0.56 |
chr17_46504191_46504342 | 1.26 |
SKAP1 |
src kinase associated phosphoprotein 1 |
3286 |
0.19 |
chr8_66750145_66750362 | 1.23 |
PDE7A |
phosphodiesterase 7A |
730 |
0.78 |
chr2_204572665_204572956 | 1.22 |
CD28 |
CD28 molecule |
1394 |
0.52 |
chr7_8010063_8010681 | 1.21 |
AC006042.7 |
|
838 |
0.45 |
chr1_29242251_29242585 | 1.21 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
1327 |
0.43 |
chr20_35273248_35273480 | 1.21 |
SLA2 |
Src-like-adaptor 2 |
920 |
0.49 |
chr11_117861027_117861203 | 1.21 |
IL10RA |
interleukin 10 receptor, alpha |
4006 |
0.22 |
chr22_40302613_40302912 | 1.21 |
GRAP2 |
GRB2-related adaptor protein 2 |
5649 |
0.19 |
chr10_51502200_51502361 | 1.19 |
AGAP7 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 7 |
15953 |
0.19 |
chr2_158291882_158292250 | 1.19 |
CYTIP |
cytohesin 1 interacting protein |
3860 |
0.26 |
chr5_130882612_130883040 | 1.19 |
RAPGEF6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
14100 |
0.29 |
chr13_74807358_74807666 | 1.18 |
ENSG00000206617 |
. |
55839 |
0.16 |
chr12_55378965_55379116 | 1.16 |
TESPA1 |
thymocyte expressed, positive selection associated 1 |
510 |
0.83 |
chr19_4915707_4915936 | 1.16 |
ARRDC5 |
arrestin domain containing 5 |
12942 |
0.12 |
chr1_150082423_150082787 | 1.13 |
PLEKHO1 |
pleckstrin homology domain containing, family O member 1 |
38768 |
0.11 |
chr5_35853538_35853785 | 1.12 |
IL7R |
interleukin 7 receptor |
864 |
0.63 |
chr12_15111636_15111984 | 1.11 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
2390 |
0.25 |
chrX_13103844_13104411 | 1.11 |
FAM9C |
family with sequence similarity 9, member C |
41326 |
0.19 |
chr1_198608588_198608957 | 1.11 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
480 |
0.86 |
chr2_120988902_120989053 | 1.11 |
TMEM185B |
transmembrane protein 185B |
7993 |
0.17 |
chr4_143323755_143324370 | 1.09 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
28350 |
0.27 |
chr10_104926250_104926401 | 1.08 |
NT5C2 |
5'-nucleotidase, cytosolic II |
8414 |
0.23 |
chr12_105114147_105114900 | 1.08 |
ENSG00000264295 |
. |
129112 |
0.05 |
chr5_42993896_42994430 | 1.06 |
CTD-2035E11.3 |
|
24368 |
0.15 |
chr22_40858929_40859404 | 1.06 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
256 |
0.92 |
chr3_105585580_105586174 | 1.06 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
2010 |
0.51 |
chr1_198612556_198613143 | 1.04 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
4557 |
0.28 |
chr10_47639246_47639397 | 1.04 |
ANTXRLP1 |
anthrax toxin receptor-like pseudogene 1 |
5470 |
0.23 |
chr6_36512638_36512811 | 1.04 |
STK38 |
serine/threonine kinase 38 |
2523 |
0.22 |
chr3_151917021_151917172 | 1.03 |
MBNL1 |
muscleblind-like splicing regulator 1 |
68733 |
0.12 |
chr1_226919798_226919959 | 1.02 |
ITPKB |
inositol-trisphosphate 3-kinase B |
5281 |
0.26 |
chr6_44900327_44900782 | 1.02 |
SUPT3H |
suppressor of Ty 3 homolog (S. cerevisiae) |
22693 |
0.28 |
chrX_19813800_19813951 | 1.01 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
3994 |
0.35 |
chr3_52305451_52305846 | 1.01 |
ENSG00000199150 |
. |
3269 |
0.11 |
chr15_70851492_70851719 | 1.00 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
143015 |
0.05 |
chr17_29637048_29637296 | 1.00 |
EVI2B |
ecotropic viral integration site 2B |
3930 |
0.16 |
chr17_14104811_14105106 | 1.00 |
AC005224.2 |
|
8847 |
0.21 |
chr12_25205029_25205380 | 1.00 |
LRMP |
lymphoid-restricted membrane protein |
1 |
0.98 |
chr1_89737127_89737489 | 1.00 |
GBP5 |
guanylate binding protein 5 |
762 |
0.66 |
chr7_138790255_138790726 | 1.00 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
3610 |
0.26 |
chr3_71542168_71542650 | 0.99 |
ENSG00000221264 |
. |
48831 |
0.15 |
chr3_113933616_113933798 | 0.99 |
RP11-553L6.2 |
|
469 |
0.8 |
chr19_16477276_16478284 | 0.99 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
5016 |
0.17 |
chr18_60986176_60986699 | 0.99 |
BCL2 |
B-cell CLL/lymphoma 2 |
176 |
0.94 |
chr2_85536451_85536819 | 0.98 |
ENSG00000221579 |
. |
10478 |
0.11 |
chr9_123686452_123686718 | 0.98 |
TRAF1 |
TNF receptor-associated factor 1 |
4462 |
0.25 |
chr13_41554452_41554603 | 0.98 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
1891 |
0.36 |
chr1_29253817_29254129 | 0.97 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
12882 |
0.18 |
chr7_138779169_138779413 | 0.97 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
14809 |
0.2 |
chr1_101703704_101704393 | 0.97 |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
1604 |
0.28 |
chr5_130603474_130603777 | 0.96 |
CDC42SE2 |
CDC42 small effector 2 |
3832 |
0.34 |
chr6_159071306_159071615 | 0.96 |
SYTL3 |
synaptotagmin-like 3 |
414 |
0.83 |
chr9_274295_274630 | 0.96 |
DOCK8 |
dedicator of cytokinesis 8 |
1392 |
0.34 |
chr18_2659637_2659788 | 0.96 |
SMCHD1 |
structural maintenance of chromosomes flexible hinge domain containing 1 |
3826 |
0.19 |
chr20_52225841_52226018 | 0.95 |
ZNF217 |
zinc finger protein 217 |
498 |
0.82 |
chr5_43019046_43019566 | 0.95 |
CTD-2201E18.3 |
|
393 |
0.65 |
chr15_70851080_70851231 | 0.95 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
143465 |
0.05 |
chr13_99953854_99954138 | 0.95 |
GPR183 |
G protein-coupled receptor 183 |
5663 |
0.22 |
chr2_202126146_202126672 | 0.95 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
270 |
0.92 |
chr2_148602296_148602520 | 0.94 |
ACVR2A |
activin A receptor, type IIA |
223 |
0.94 |
chr21_15917916_15918619 | 0.94 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
395 |
0.89 |
chr6_154568354_154568864 | 0.94 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
53 |
0.99 |
chr10_73843517_73843668 | 0.93 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
4494 |
0.27 |
chr7_138779576_138780000 | 0.93 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
14312 |
0.2 |
chr14_81686778_81687116 | 0.93 |
GTF2A1 |
general transcription factor IIA, 1, 19/37kDa |
319 |
0.9 |
chr10_111770759_111770972 | 0.93 |
ADD3 |
adducin 3 (gamma) |
3143 |
0.26 |
chr19_4301680_4301841 | 0.93 |
TMIGD2 |
transmembrane and immunoglobulin domain containing 2 |
622 |
0.51 |
chr16_89831548_89831767 | 0.93 |
FANCA |
Fanconi anemia, complementation group A |
20187 |
0.11 |
chr1_220263314_220263670 | 0.93 |
BPNT1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
301 |
0.86 |
chr17_37932472_37932886 | 0.93 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
1799 |
0.27 |
chr14_22967837_22967993 | 0.92 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
11744 |
0.1 |
chr2_68962051_68962936 | 0.92 |
ARHGAP25 |
Rho GTPase activating protein 25 |
479 |
0.86 |
chr2_47339184_47339335 | 0.92 |
C2orf61 |
chromosome 2 open reading frame 61 |
39175 |
0.14 |
chr6_108143886_108144261 | 0.92 |
SCML4 |
sex comb on midleg-like 4 (Drosophila) |
1443 |
0.53 |
chr1_169679248_169679951 | 0.92 |
SELL |
selectin L |
1240 |
0.48 |
chr2_214011890_214012241 | 0.92 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
1288 |
0.61 |
chr6_88355044_88355273 | 0.92 |
ORC3 |
origin recognition complex, subunit 3 |
5490 |
0.23 |
chrX_62780920_62781228 | 0.91 |
ENSG00000235437 |
. |
123 |
0.98 |
chr1_29245238_29245389 | 0.91 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
4222 |
0.22 |
chr4_40203939_40204397 | 0.91 |
RHOH |
ras homolog family member H |
2204 |
0.34 |
chr5_43065222_43065498 | 0.91 |
CTD-2201E18.3 |
|
2161 |
0.24 |
chr12_867200_867553 | 0.91 |
WNK1 |
WNK lysine deficient protein kinase 1 |
4644 |
0.24 |
chr17_41393290_41393559 | 0.90 |
ENSG00000236383 |
. |
10086 |
0.14 |
chrX_44203680_44203969 | 0.90 |
EFHC2 |
EF-hand domain (C-terminal) containing 2 |
906 |
0.71 |
chr6_44899717_44900076 | 0.90 |
SUPT3H |
suppressor of Ty 3 homolog (S. cerevisiae) |
23351 |
0.28 |
chrY_18031093_18031244 | 0.90 |
ENSG00000252664 |
. |
143478 |
0.05 |
chr15_45006518_45006669 | 0.90 |
B2M |
beta-2-microglobulin |
2878 |
0.2 |
chr2_197030084_197030285 | 0.90 |
STK17B |
serine/threonine kinase 17b |
5540 |
0.21 |
chr7_24460976_24461127 | 0.90 |
ENSG00000206877 |
. |
115900 |
0.06 |
chr1_226251298_226251924 | 0.90 |
H3F3A |
H3 histone, family 3A |
67 |
0.97 |
chr15_86233199_86233602 | 0.89 |
RP11-815J21.1 |
|
10940 |
0.11 |
chr17_56708788_56708939 | 0.89 |
ENSG00000212195 |
. |
334 |
0.83 |
chr2_194347562_194347833 | 0.89 |
NA |
NA |
> 106 |
NA |
chr7_92347129_92347835 | 0.88 |
ENSG00000206763 |
. |
16354 |
0.24 |
chr12_101190101_101190393 | 0.88 |
ANO4 |
anoctamin 4 |
1511 |
0.51 |
chr19_17957141_17957427 | 0.88 |
JAK3 |
Janus kinase 3 |
1542 |
0.26 |
chr9_95824479_95824630 | 0.87 |
SUSD3 |
sushi domain containing 3 |
3493 |
0.22 |
chr6_144631915_144632066 | 0.87 |
UTRN |
utrophin |
19025 |
0.22 |
chr6_44900994_44901181 | 0.87 |
SUPT3H |
suppressor of Ty 3 homolog (S. cerevisiae) |
22160 |
0.28 |
chr5_134880102_134880446 | 0.87 |
NEUROG1 |
neurogenin 1 |
8635 |
0.17 |
chr2_207115371_207115541 | 0.87 |
ENSG00000252716 |
. |
9482 |
0.15 |
chr1_148766534_148766949 | 0.87 |
ENSG00000206968 |
. |
361 |
0.9 |
chr7_38393634_38393798 | 0.87 |
AMPH |
amphiphysin |
108997 |
0.07 |
chr10_6585169_6585583 | 0.87 |
PRKCQ |
protein kinase C, theta |
36825 |
0.22 |
chrX_118814465_118814616 | 0.87 |
SEPT6 |
septin 6 |
12252 |
0.17 |
chr14_90083201_90083388 | 0.86 |
FOXN3 |
forkhead box N3 |
2180 |
0.23 |
chr1_192842951_192843102 | 0.86 |
ENSG00000223075 |
. |
2089 |
0.41 |
chr7_66096542_66096781 | 0.86 |
KCTD7 |
potassium channel tetramerization domain containing 7 |
2716 |
0.29 |
chr20_43599792_43600332 | 0.86 |
STK4 |
serine/threonine kinase 4 |
4895 |
0.16 |
chr11_86792508_86792683 | 0.86 |
TMEM135 |
transmembrane protein 135 |
43513 |
0.2 |
chr21_36901015_36901338 | 0.85 |
ENSG00000211590 |
. |
191837 |
0.03 |
chr12_1711071_1711223 | 0.85 |
FBXL14 |
F-box and leucine-rich repeat protein 14 |
7816 |
0.21 |
chr3_159628787_159629360 | 0.85 |
SCHIP1 |
schwannomin interacting protein 1 |
58345 |
0.11 |
chrX_78401406_78401924 | 0.85 |
GPR174 |
G protein-coupled receptor 174 |
24804 |
0.27 |
chr5_156605931_156606082 | 0.85 |
ITK |
IL2-inducible T-cell kinase |
1831 |
0.25 |
chr12_32081427_32081645 | 0.85 |
ENSG00000252584 |
. |
12895 |
0.21 |
chr10_173746_173998 | 0.85 |
ZMYND11 |
zinc finger, MYND-type containing 11 |
6533 |
0.24 |
chr4_38806079_38806484 | 0.85 |
TLR1 |
toll-like receptor 1 |
131 |
0.95 |
chr14_22982783_22983297 | 0.85 |
TRAJ15 |
T cell receptor alpha joining 15 |
15540 |
0.1 |
chr5_39201497_39202174 | 0.85 |
FYB |
FYN binding protein |
1294 |
0.59 |
chr21_26378043_26378194 | 0.85 |
ENSG00000232512 |
. |
95327 |
0.09 |
chr13_99955996_99956281 | 0.85 |
GPR183 |
G protein-coupled receptor 183 |
3521 |
0.25 |
chr5_177236761_177236962 | 0.85 |
FAM153A |
family with sequence similarity 153, member A |
26462 |
0.14 |
chr1_147994280_147994770 | 0.85 |
ENSG00000212456 |
. |
379 |
0.87 |
chr9_71510900_71511280 | 0.84 |
ENSG00000207000 |
. |
39805 |
0.16 |
chr1_148604512_148604943 | 0.84 |
ENSG00000207205 |
. |
345 |
0.92 |
chr13_41588793_41589349 | 0.84 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
4379 |
0.23 |
chr22_40297430_40297673 | 0.84 |
GRAP2 |
GRB2-related adaptor protein 2 |
438 |
0.81 |
chr2_106392347_106392498 | 0.84 |
NCK2 |
NCK adaptor protein 2 |
30234 |
0.23 |
chr17_29136154_29136502 | 0.84 |
CRLF3 |
cytokine receptor-like factor 3 |
15361 |
0.12 |
chr12_111043580_111043895 | 0.84 |
TCTN1 |
tectonic family member 1 |
8095 |
0.15 |
chr20_47439188_47439680 | 0.84 |
PREX1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
4986 |
0.3 |
chr20_45984269_45984938 | 0.84 |
ZMYND8 |
zinc finger, MYND-type containing 8 |
202 |
0.91 |
chr5_159896497_159896765 | 0.83 |
ENSG00000265237 |
. |
4778 |
0.19 |
chr11_48005187_48005436 | 0.83 |
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
3032 |
0.28 |
chr1_204482636_204482787 | 0.83 |
MDM4 |
Mdm4 p53 binding protein homolog (mouse) |
2800 |
0.25 |
chr17_78074599_78074750 | 0.83 |
GAA |
glucosidase, alpha; acid |
681 |
0.66 |
chr5_6828115_6828430 | 0.83 |
ENSG00000200243 |
. |
20303 |
0.27 |
chr8_116876579_116876730 | 0.83 |
TRPS1 |
trichorhinophalangeal syndrome I |
54755 |
0.17 |
chr2_175498427_175499207 | 0.82 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
490 |
0.83 |
chr1_229642144_229642295 | 0.82 |
NUP133 |
nucleoporin 133kDa |
1854 |
0.24 |
chr6_42539508_42540122 | 0.82 |
UBR2 |
ubiquitin protein ligase E3 component n-recognin 2 |
8015 |
0.23 |
chr15_34620156_34620427 | 0.82 |
SLC12A6 |
solute carrier family 12 (potassium/chloride transporter), member 6 |
8754 |
0.11 |
chr17_76768494_76768645 | 0.82 |
CYTH1 |
cytohesin 1 |
9785 |
0.19 |
chr8_21341401_21341552 | 0.82 |
ENSG00000266713 |
. |
10063 |
0.28 |
chr2_242556723_242557374 | 0.82 |
THAP4 |
THAP domain containing 4 |
132 |
0.94 |
chr3_113932374_113933030 | 0.82 |
RP11-553L6.2 |
|
458 |
0.8 |
chr4_38320095_38320594 | 0.81 |
ENSG00000221495 |
. |
80110 |
0.11 |
chrX_19815653_19816006 | 0.81 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
2040 |
0.46 |
chr11_104788706_104789238 | 0.81 |
RP11-693N9.2 |
|
8330 |
0.2 |
chr12_127256565_127256739 | 0.81 |
ENSG00000239776 |
. |
394020 |
0.01 |
chr12_124941723_124942278 | 0.81 |
NCOR2 |
nuclear receptor corepressor 2 |
26315 |
0.25 |
chr1_114474532_114474797 | 0.81 |
HIPK1 |
homeodomain interacting protein kinase 1 |
1314 |
0.32 |
chr16_79320926_79321088 | 0.81 |
ENSG00000222244 |
. |
22656 |
0.27 |
chr1_204475159_204475328 | 0.81 |
MDM4 |
Mdm4 p53 binding protein homolog (mouse) |
10268 |
0.17 |
chr13_79176575_79176905 | 0.80 |
POU4F1 |
POU class 4 homeobox 1 |
933 |
0.56 |
chr19_5628752_5628903 | 0.80 |
SAFB2 |
scaffold attachment factor B2 |
4770 |
0.16 |
chr12_92540731_92541030 | 0.80 |
RP11-796E2.4 |
|
923 |
0.43 |
chr1_148241598_148242095 | 0.80 |
ENSG00000207501 |
. |
381 |
0.9 |
chr3_187637243_187637630 | 0.80 |
BCL6 |
B-cell CLL/lymphoma 6 |
173921 |
0.03 |
chr7_130916444_130916595 | 0.80 |
MKLN1 |
muskelin 1, intracellular mediator containing kelch motifs |
53302 |
0.15 |
chr2_235403089_235403368 | 0.80 |
ARL4C |
ADP-ribosylation factor-like 4C |
2016 |
0.5 |
chr17_33774740_33774936 | 0.80 |
SLFN13 |
schlafen family member 13 |
425 |
0.78 |
chr13_48985600_48986692 | 0.80 |
LPAR6 |
lysophosphatidic acid receptor 6 |
14897 |
0.27 |
chr1_225629722_225629873 | 0.80 |
LBR |
lamin B receptor |
13170 |
0.18 |
chr2_30458431_30458703 | 0.80 |
LBH |
limb bud and heart development |
3521 |
0.29 |
chr19_48760988_48761397 | 0.80 |
CARD8 |
caspase recruitment domain family, member 8 |
1989 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.4 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.7 | 2.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.6 | 0.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.6 | 0.6 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.6 | 2.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.6 | 1.7 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.5 | 1.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 1.5 | GO:0002664 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.5 | 2.4 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.5 | 1.4 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.5 | 1.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 1.8 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 3.5 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 1.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.4 | 0.9 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 1.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.4 | 2.1 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.4 | 4.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.9 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.4 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 1.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 1.4 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.4 | 1.4 | GO:0002507 | tolerance induction(GO:0002507) |
0.4 | 2.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 1.4 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.3 | 1.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 1.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 1.0 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 1.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.3 | 1.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.6 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.3 | 0.9 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.9 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 0.6 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.3 | 1.7 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.3 | 0.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.3 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.3 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.3 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.8 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 2.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 1.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 1.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 1.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.2 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.2 | 0.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.2 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 1.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.7 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 2.3 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 0.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 0.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.2 | 0.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.2 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 0.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 1.0 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 0.8 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 1.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.6 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 0.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 0.6 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.2 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.2 | 0.6 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 4.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 4.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 4.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.2 | 0.4 | GO:0032607 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.7 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 0.5 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.2 | 1.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 2.8 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 2.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.7 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.8 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.2 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.2 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.2 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.2 | 0.6 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.5 | GO:2000380 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.2 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.2 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.2 | GO:0046006 | positive regulation of activated T cell proliferation(GO:0042104) regulation of activated T cell proliferation(GO:0046006) |
0.2 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.6 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.2 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.2 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.3 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.3 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 1.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.3 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 0.6 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 1.7 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.1 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.1 | 0.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.8 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.6 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.7 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 1.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.7 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.4 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 1.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.6 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 2.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.6 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 5.9 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.5 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.4 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.4 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 1.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.9 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.5 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.1 | 2.3 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
0.1 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.5 | GO:0021604 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.1 | 2.0 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.2 | GO:0014889 | muscle atrophy(GO:0014889) |
0.1 | 1.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 3.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 2.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 1.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.3 | GO:0090312 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.1 | GO:0051445 | regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
0.1 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 2.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.3 | GO:0048670 | collateral sprouting(GO:0048668) regulation of collateral sprouting(GO:0048670) |
0.1 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 1.0 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.3 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.1 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 1.6 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.5 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.3 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 1.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 0.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.4 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.4 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 1.1 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.5 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.4 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.1 | 0.4 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.1 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.7 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 0.6 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.4 | GO:0033233 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.3 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 4.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 2.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.8 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.2 | GO:1904375 | regulation of establishment of protein localization to plasma membrane(GO:0090003) regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.1 | 0.7 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 3.6 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.1 | 0.2 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.5 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.1 | 0.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 1.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 12.2 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.1 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.1 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.3 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 7.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.3 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.1 | 0.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 1.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.4 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 2.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.5 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 1.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.4 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 0.2 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.2 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.6 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.2 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 0.5 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.4 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.6 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.2 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.9 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.3 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.2 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 2.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 2.8 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 6.2 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.5 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.2 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of cell junction assembly(GO:1901888) regulation of adherens junction organization(GO:1903391) |
0.1 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.2 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.1 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.5 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 3.0 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.1 | GO:0046021 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 5.8 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 1.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.4 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.2 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.1 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.2 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.1 | 0.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 1.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.3 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.4 | GO:0036230 | granulocyte activation(GO:0036230) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.2 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 1.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.4 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.0 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 2.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.0 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.0 | 0.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0052646 | glycerol-3-phosphate metabolic process(GO:0006072) alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.0 | GO:0098732 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.0 | 0.9 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.0 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.0 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.1 | GO:0023058 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.0 | 2.8 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 2.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.3 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 2.5 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 1.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.4 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.1 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 1.1 | GO:0072655 | protein targeting to mitochondrion(GO:0006626) establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.1 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.6 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 3.2 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.1 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.4 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.4 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.4 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 4.7 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.1 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 1.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.4 | GO:0035194 | posttranscriptional gene silencing(GO:0016441) posttranscriptional gene silencing by RNA(GO:0035194) |
0.0 | 0.6 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 2.7 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.5 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.0 | 0.3 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0060263 | regulation of hydrogen peroxide metabolic process(GO:0010310) regulation of respiratory burst(GO:0060263) |
0.0 | 0.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.9 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) cellular response to ammonium ion(GO:0071242) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.2 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.5 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.5 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 2.5 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 1.0 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.6 | GO:0000723 | telomere maintenance(GO:0000723) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) telomere formation via telomerase(GO:0032203) |
0.0 | 0.0 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.2 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0016458 | gene silencing(GO:0016458) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0051324 | prophase(GO:0051324) |
0.0 | 0.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.0 | 0.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.6 | GO:0016579 | protein deubiquitination(GO:0016579) protein modification by small protein removal(GO:0070646) |
0.0 | 0.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.7 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.8 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.0 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.1 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.0 | 0.4 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.0 | 0.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.0 | 0.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.3 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.2 | GO:0015879 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 0.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 3.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.6 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.0 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.2 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.2 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.0 | 0.0 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.0 | GO:0065005 | plasma lipoprotein particle assembly(GO:0034377) protein-lipid complex assembly(GO:0065005) |
0.0 | 0.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.0 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:1901989 | positive regulation of cell cycle phase transition(GO:1901989) positive regulation of mitotic cell cycle phase transition(GO:1901992) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.1 | GO:0043543 | protein acylation(GO:0043543) |
0.0 | 0.2 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.0 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0032623 | interleukin-2 production(GO:0032623) |
0.0 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.4 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 0.2 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:2000278 | regulation of DNA biosynthetic process(GO:2000278) |
0.0 | 0.0 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0090278 | negative regulation of peptide hormone secretion(GO:0090278) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.1 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 4.9 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.4 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 1.0 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.0 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.0 | GO:0071706 | tumor necrosis factor superfamily cytokine production(GO:0071706) |
0.0 | 0.0 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.0 | GO:0032675 | interleukin-6 production(GO:0032635) regulation of interleukin-6 production(GO:0032675) |
0.0 | 0.1 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
0.0 | 0.0 | GO:0010535 | regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.0 | 0.0 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.0 | 0.0 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.0 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:0061365 | positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 2.0 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 0.1 | GO:0042596 | fear response(GO:0042596) |
0.0 | 0.0 | GO:0060491 | regulation of cell projection assembly(GO:0060491) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.2 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.1 | GO:0000084 | mitotic S phase(GO:0000084) |
0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.3 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.0 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.5 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.0 | 0.2 | GO:0007126 | meiotic nuclear division(GO:0007126) |
0.0 | 0.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0032892 | positive regulation of organic acid transport(GO:0032892) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.0 | GO:0015840 | urea transport(GO:0015840) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 1.8 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 1.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 0.4 | GO:0001740 | Barr body(GO:0001740) |
0.4 | 3.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 3.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.6 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.2 | 1.7 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 1.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 2.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 2.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 1.2 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 3.1 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.0 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 1.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.4 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 1.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 2.1 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 4.6 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.4 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 2.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 4.9 | GO:0016605 | PML body(GO:0016605) |
0.1 | 5.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 1.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 1.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 2.0 | GO:0032154 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 0.2 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.1 | GO:0032040 | preribosome(GO:0030684) small-subunit processome(GO:0032040) |
0.1 | 0.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.6 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 1.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 2.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 4.9 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 2.4 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.3 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.4 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 1.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.5 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.6 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 8.7 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.6 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.6 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 2.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 2.6 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.9 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.0 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.7 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 4.5 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 2.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 6.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.1 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.0 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 5.0 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 4.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 4.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 1.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 1.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 1.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.0 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 1.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.0 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 4.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 1.1 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 3.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.7 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 1.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 5.8 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 3.4 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 28.8 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.4 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 1.5 | GO:0031985 | Golgi cisterna(GO:0031985) Golgi cisterna membrane(GO:0032580) |
0.0 | 0.0 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.7 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 4.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 1.5 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 34.8 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.6 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0000803 | sex chromosome(GO:0000803) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 3.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 1.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 10.2 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 1.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.1 | GO:0031248 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.4 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.0 | 0.8 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.3 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.0 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.9 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 4.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 33.1 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.8 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 3.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 1.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.4 | 1.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 1.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 5.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 2.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 0.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.3 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 6.8 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 0.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 2.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 0.8 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 1.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.3 | 0.8 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 3.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 2.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 1.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.6 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 2.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 1.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 1.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 2.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 2.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 2.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 2.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 3.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 2.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 1.1 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.2 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.2 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.2 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 1.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 7.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 1.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.9 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.5 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 7.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.4 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 1.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 1.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 3.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.6 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 1.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 2.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.5 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.1 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 2.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.4 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.9 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.4 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 2.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 2.3 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 1.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 3.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.8 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 1.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 2.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 4.2 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.5 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.1 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.3 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.2 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.2 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 1.5 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 6.5 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.9 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 2.3 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.7 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.3 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.1 | 0.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 1.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 1.8 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.5 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.4 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 2.0 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 1.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.6 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 14.7 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.7 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 1.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 1.5 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 3.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.5 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.3 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.3 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 2.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 5.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.0 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 6.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 1.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.6 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.4 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 11.3 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 1.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.0 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.0 | GO:0099528 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 1.1 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.0 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 2.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.0 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.7 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 4.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 32.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.0 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.3 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 23.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 3.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 7.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 8.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 2.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 2.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 3.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 5.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 4.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 4.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 4.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 3.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 2.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 7.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 6.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 3.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 5.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 4.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 3.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 4.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 3.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.8 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 0.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 2.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 2.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 3.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 6.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 3.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 5.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 1.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 6.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.3 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 4.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 2.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 3.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 3.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 4.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.7 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.1 | 1.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 2.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.9 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 5.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 3.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.2 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 3.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 2.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 3.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 1.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 2.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 0.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 4.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 1.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 1.3 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.0 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.3 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 3.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |